Vivimed Labs quarterly results and financials

Vivimed Labs (VIVIMEDLAB)₹5.40−0.18%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (consolidated), Vivimed Labs reported sales of ₹12.01 Cr, down 53.8% from Mar 2025, and net profit of −₹147 Cr. For the year to Mar 2026, sales were ₹70.06 Cr and net profit −₹176 Cr.

Sales (Mar 2026): ₹12.01 Cr
Net profit (Mar 2026): −₹147 Cr
Sales (FY Mar 2026): ₹70.06 Cr
Net profit (FY Mar 2026): −₹176 Cr
EPS (Mar 2026): ₹−17.69
Borrowings (Mar 2026): ₹397 Cr

Company filings, consolidated accounts; latest reported quarter Mar 2026

Vivimed Labs quarterly results

₹ crore unless stated; each column is a quarter.

Vivimed Labs Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	35.02	34.01	41.01	39.03	29.02	24.99	37.03	26.02	21.01	21.02	15.99	12.01
Expenses	35.93	39.90	39.89	66.84	39.94	24.96	34.92	27.94	21.97	21.94	26.95	152
Operating Profit	0.00	−5.99	0.99	−27.94	−10.99	−0.99	0.99	−1.99	0.00	−0.99	−10.99	−140
OPM %	−0.9%	−18.1%	3.1%	−74.1%	−37.0%	−2.6%	2.9%	−10.0%	−1.3%	−4.6%	−68.1%	−1,169.1%
Other Income	0.00	2.01	0.00	8.01	0.00	0.00	0.00	4.01	0.00	0.00	0.00	6.01
Interest	10.99	11.99	12.99	−32.96	0.00	0.00	0.00	1.99	0.99	1.99	0.99	0.99
Depreciation	4.99	4.99	4.99	5.99	3.99	3.99	6.99	5.99	4.99	4.99	4.99	11.98
Profit before tax	−16.05	−20.06	−17.06	7.02	−15.04	−5.01	−6.02	−5.02	−5.01	−7.02	−17.05	−148
Tax %	0.0%	0.0%	−3.0%	21.0%	0.0%	0.0%	0.0%	2.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	−16.01	−20.02	−16.02	5.01	−15.02	−5.01	−6.01	−6.01	−5.01	−7.01	−17.01	−147
EPS (Rs)	−1.87	−2.44	−1.93	0.62	−1.83	−0.61	−0.71	−0.67	−0.65	−0.87	−1.99	−17.69

Vivimed Labs profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Vivimed Labs Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,346	1,463	1,187	1,316	1,060	861	237	187	149	116	70.06	70.03
Expenses	1,108	1,055	969	1,133	1,046	829	245	374	182	129	222	223
Operating Profit	234	403	215	180	9.98	31.94	−7.99	−187	−32.93	−12.98	−152	−152
OPM %	16.9%	28.0%	18.0%	13.9%	1.0%	3.7%	−3.3%	−100.1%	−22.1%	−11.0%	−218.1%	−216.7%
Other Income	11.02	8.01	10.01	23.01	8.01	10.01	1.01	1.01	10.01	4.01	6.01	6.01
Interest	83.90	67.90	81.93	69.91	60.93	55.94	39.94	35.98	2.99	2.99	3.99	4.96
Depreciation	60.88	57.92	55.85	66.87	66.91	55.86	17.96	108	19.96	19.96	25.95	26.95
Profit before tax	100	287	86.30	66.18	−109	−70.22	−65.18	−332	−46.16	−32.10	−177	−177
Tax %	16.0%	24.9%	11.0%	12.9%	0.0%	3.0%	4.0%	−1.0%	−1.0%	0.0%	0.0%	—
Net Profit	84.10	214	76.09	57.07	−109	−72.06	−67.99	−329	−45.01	−32.01	−176	−176
EPS (Rs)	10.29	26.30	9.41	6.92	−13.12	−8.63	−8.13	−39.48	−5.46	−3.83	−21.22	−21.20
Dividend payout %	0.0%	2.0%	4.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Vivimed Labs balance sheet

₹ crore, at each year end.

Vivimed Labs Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16.00	15.99	15.98	16.99	17.01	16.99	17.01	16.99	17.04	17.03	17.03	17.04
Reserves	479	505	717	884	601	492	415	348	23.02	−22.04	−52.06	−227
Borrowings	1,074	1,014	1,009	1,148	1,278	1,266	326	359	379	377	376	397
Other Liabilities	325	517	315	341	429	430	529	540	655	577	578	565
Total Liabilities	1,894	2,051	2,057	2,390	2,325	2,205	1,286	1,263	1,074	948	919	751
Fixed Assets	811	812	876	1,032	962	1,041	500	518	435	417	407	385
CWIP	90.23	94.14	76.15	65.13	122	89.12	60.14	40.07	21.03	21.03	17.03	18.03
Investments	2.99	2.99	2.99	2.99	2.99	85.73	198	198	198	168	167	181
Other Assets	990	1,142	1,102	1,289	1,237	988	528	506	421	342	328	170
Inventories	430	501	483	539	563	501	255	240	161	63.83	58.85	12.96
Trade receivables	331	326	200	276	356	250	108	87.17	74.11	83.15	74.11	45.04
Cash & equivalents	26.98	30.96	54.94	98.87	94.88	49.98	5.99	6.99	3.99	1.99	0.99	0.99
Total Assets	1,894	2,051	2,057	2,390	2,325	2,205	1,286	1,263	1,074	948	919	751

Vivimed Labs cash flow

₹ crore, for each year.

Vivimed Labs Cash flow
	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from operating activity	—	140	153	57.85	20.96	421	79.73	565	27.91	34.93	−23.92	−1.99
Cash from investing activity	—	−107	−190	−68.15	−164	−89.19	−196	405	−16.02	−5.01	28.03	−5.01
Cash from financing activity	—	−41.97	41.01	35.01	186	−338	71.93	−1,015	−9.99	−33.99	−6.01	5.01
Net cash flow	—	−7.97	3.98	24.90	43.83	−4.98	−43.85	−43.81	0.99	−2.99	−1.99	−0.99
Capex	158	124	0.00	68.16	163	88.66	112	0.00	16.33	4.95	2.03	4.51
Free cash flow	—	16.04	95.20	−11.03	−142	334	−33.05	1,086	11.02	30.05	−26.04	−6.01
CFO / OP %	—	63.0%	66.0%	23.0%	30.0%	243.0%	972.0%	1,719.9%	−352.1%	−19.1%	72.9%	13.0%

Vivimed Labs ratios

Working-capital days and returns, by year.

Vivimed Labs Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	87	88	50	85	99	86	46	134	145	203	233	236
Inventory days	244	294	329	411	397	396	263	573	216	327	358	63
Days payable	106	97	121	153	206	178	34	99	73	224	239	262
Cash conversion cycle	224	285	258	342	288	303	274	607	286	305	351	36
Working capital days	44	59	56	122	69	217	78	196	−14	−170	−254	−1,467
ROCE %	11.0%	12.0%	22.0%	9.0%	7.0%	−3.0%	−1.0%	−3.0%	−52.0%	−11.0%	−8.0%	−65.0%

Vivimed Labs: frequently asked questions

What are the latest quarterly results of Vivimed Labs?

For the Mar 2026 quarter, Vivimed Labs reported sales of ₹12.01 Cr, down 53.8% year on year and net profit of −₹147 Cr. The operating margin was −1,169.1%.

What is the annual revenue of Vivimed Labs?

Vivimed Labs' sales for the year to Mar 2026 were ₹70.06 Cr; over the last twelve months they were ₹70.03 Cr.

What is the net profit of Vivimed Labs?

Net profit for the year to Mar 2026 was −₹176 Cr, and −₹176 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−21.20.

How much debt does Vivimed Labs have?

Vivimed Labs reported borrowings of ₹397 Cr at Mar 2026, against cash and equivalents of ₹0.99 Cr.

What is the free cash flow of Vivimed Labs?

Cash from operations was −₹1.99 Cr in the year to Mar 2025; after capital spending, free cash flow was −₹6.01 Cr.

Loading…